Instructional Video10:19
msvgo

Biotechnology in Medicine

K - 12th
It explains various applications of biotechnology in medicine including insulin production, gene therapy and molecular diagnosis
Instructional Video4:43
FuseSchool

What Is Cystic Fibrosis

6th - Higher Ed
Cystic fibrosis is a genetic disease. It is caused by a defective gene on one of the chromosomes which has been inherited from the parents. The severity varies greatly from person to person, and largely depends on how much the lungs are...
Instructional Video5:54
FuseSchool

Gene Technology

6th - Higher Ed
Gene technology includes a range of activities that take advantage of genetic variation, modifying genes and transferring genes to new hosts. It includes genetic engineering and genetic testing. Gene technology is the term given to a...
Instructional Video8:02
Professor Dave Explains

Biotechnology: Genetic Modification, Cloning, Stem Cells, and Beyond

12th - Higher Ed
In this biology playlist, we've learned so much about DNA and living organisms! Well, so has mankind over the past century, and oh, what we have done with this knowledge! It's pretty incredible when you stop and think about it. Let's go...
Instructional Video5:15
Professor Dave Explains

Gene Therapy

12th - Higher Ed
When we looked at some areas of biotechnology earlier in the series, we briefly touched on gene therapy, without saying much about what it is. Now we are ready to dive into this topic and see what it is all about. If a person has a...
News Clip11:18
Curated Video

The million dollar drug that patients can't access

9th - Higher Ed
Glybera is a made-in-Canada discovery that made history, becoming the world's first drug approved to treat a genetic disease. But when it went on the market at a price of $1 million, it was immediately labelled the most expensive drug in...
News Clip6:06
Curated Video

Montreal patient undergoes genetic procedure for frontotemporal dementia

9th - Higher Ed
Two doctors from the Montreal Neurological Institute-Hospital, including Dr. Simon Ducharme, performed a genetic procedure on a patient in hopes of slowing down or halting the disease's progression. This is the first time this gene...
News Clip1:54
Curated Video

8-year-old from Valley Stream becomes first in NY to undergo gene therapy for rare disease

9th - Higher Ed
It involved removing stem cells from Yusef, genetically altering them and then putting them back into his body with the hope they would cure the disease.
News Clip0:50
Curated Video

FDA Advisers to Review New Sickle Cell Treatment

9th - Higher Ed
Advisers to the Food and Drug Administration are meeting to review a gene therapy technique called CRISPR to treat sickle cell disease.
News Clip0:37
Curated Video

New Eye Treatment Cured Boy's Blindness

9th - Higher Ed
A teen in Cuba who's been legally blind can now see again thanks to new gene therapy treatments.
News Clip0:30
Curated Video

New Eye Treatment Cures Teen Boy's Blindness

9th - Higher Ed
A teenage boy who has been blind for most of his life has been cured due to new gene therapy treatments.
News Clip23:00
Curated Video

Closing the Stem Gender Gap, Woman-Owned Empire and Brain Science & Emotional Energy

9th - Higher Ed
On this episode of ChedHER: women are still vastly numbered in science, technology, engineering and math, but is that about to change? Plus, what do hair care products, popcorn, nutritional supplements and coffee have in common? They're...
News Clip1:57
Curated Video

Gene Therapy Medications Hit Record High Pricetags of More Than $2 Million

9th - Higher Ed
Gene Therapy Medications Hit Record High Pricetags of More Than $2 Million
News Clip5:15
Curated Video

Toronto boy with rare disorder gets help from groundbreaking gene therapy

9th - Higher Ed
A four-year-old boy in Toronto is now the only child in the world to receive a potential cure for his extremely rare disease. Thanks to fundraising efforts from his parents and community, and the work of doctors and researchers, he is...
News Clip2:51
Curated Video

Making Headlines: Covid red list arrivals terminal opens at Heathrow and UK temperatures to hit 27C

9th - Higher Ed
Making Headlines: Covid red list arrivals terminal opens at Heathrow and UK temperatures to hit 27C
News Clip4:56
Press Association

Medics preserve sight in children with rare genetic eye condition in world first - cutaways

Higher Ed
GVs from Moorsfields Eye Hospital after medics in the UK have become the first in the world to successfully administer a pioneering gene therapy that preserves sight in young children with an extremely rare genetic condition that usually...
News Clip2:22
Curated Video

FDA Advisers Reviewed a Sickle Cell Treatment

Higher Ed
The Food and Drug Administration says there’s an unmet need for help for patients suffering from severe sickle cell anemia. A new drug that uses gene editing could solve that.
News Clip1:54
Curated Video

Breakthrough Sickle Cell Treatments Come with Health Risks

Higher Ed
The Food and Drug Administration has approved two gene-editing treatments for patients 12 and older suffering from severe sickle cell disease, but they come with health risks doctors want patients to know about.
News Clip4:55
Press Association

Interview with Professor Manohar Bance on gene therepy child that let a baby born deaf hear

Higher Ed
Interview with Professor Manohar Bance on a gene therapy trial where a baby girl who was born deaf, can now hear unaided for the first time.
News Clip4:45
Bloomberg

How Will We Pay For Miracle Cures?

Higher Ed
Gene therapies are considered miracle cures, but their exorbitant costs, which could exceed $12 billion, might hinder access for those in need. Bloomberg Opinion columnist Lisa Jarvis highlights how two gene therapies awaiting FDA...
News Clip7:16
Bloomberg

AstraZeneca CEO Soriot on 2Q Results, China, Emerging Markets

Higher Ed
AstraZeneca reported core earnings per share for the second quarter that beat the average analyst estimate. Its CEO Pascal Soriot spoke live on "Bloomberg Markets Today" about the results, investments in China, and emerging markets. He...
News Clip4:18
Bloomberg

Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval

Higher Ed
Naoki Okamura, chief executive officer of Japanese drugmaker Astellas Pharma Inc., discusses his company's decision to acquire Iveric Bio Inc., a developer of drugs to treat age-related blindness, for about $5.9 billion. He also talks...
Stock Footage0:08
Getty Images

Drug capsules containing fragments of DNA, illustrating the concept of gene therapy

Pre-K - Higher Ed
Drug capsules containing fragments of DNA, illustrating the concept of gene therapy
Stock Footage0:08
Getty Images

Drug capsules containing fragments of DNA, illsutrating the concept of gene therapy

Pre-K - Higher Ed
Drug capsules containing fragments of DNA, illsutrating the concept of gene therapy